Zander, Serge A L <br/><br/>
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan.  [electronic resource] 

 -  Cancer research  Feb 2010 
 - 1700-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-3367  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma--drug therapy<br/>Doxorubicin--therapeutic use<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm--genetics<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, BRCA1--physiology<br/>Genes, p53--physiology<br/>Mammary Neoplasms, Animal--drug therapy<br/>Maximum Tolerated Dose<br/>Mice<br/>Mice, Knockout<br/>Phthalazines--pharmacology<br/>Piperazines--pharmacology<br/>Topoisomerase I Inhibitors<br/>Topotecan--administration & dosage